Consist with the previous report by Farge et al (2017), increased SIRT3 expression led to the transformation of metabolism in AML cells to enhanced OxPhos, a critical event in chemoresistance to Ara‐C. The gene discussed is SIRT3; the disease is acute myeloid leukemia.